RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $33,000 | -42.1% | 20,959 | -21.7% | 0.00% | – |
| Q4 2019 | $57,000 | -95.4% | 26,762 | -94.4% | 0.00% | -100.0% |
| Q1 2019 | $1,232,000 | +11.2% | 479,273 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $1,108,000 | -30.8% | 481,777 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $1,602,000 | +24.1% | 498,953 | +9.4% | 0.00% | 0.0% |
| Q2 2018 | $1,291,000 | -20.5% | 456,024 | -0.6% | 0.00% | -50.0% |
| Q1 2018 | $1,623,000 | +2286.8% | 458,597 | +2313.7% | 0.00% | – |
| Q1 2015 | $68,000 | 0.0% | 19,000 | -45.7% | 0.00% | – |
| Q3 2014 | $68,000 | -46.5% | 35,000 | 0.0% | 0.00% | – |
| Q2 2014 | $127,000 | -6.6% | 35,000 | 0.0% | 0.00% | – |
| Q1 2014 | $136,000 | +40.2% | 35,000 | +29.6% | 0.00% | – |
| Q3 2013 | $97,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |